Secondly, this study was only designed to examine the hs‐CRP levels but not to other inflammatory biomarkers such as IL‐6 and tumor necrosis factor α, which have also been identified as stronger predictors of clinical events in patients with cardiovascular diseases. This evidence concerns the gene CRP and cardiovascular disorder.